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REVIEW
Abstract: Although the clinical complications of atherosclerosis arise from developed lesions
in old age, the atherosclerotic disease is a lifelong process with roots in childhood. Endothelial
dysfunction is currently considered an early stage in the pathogenesis of atherosclerosis, which
precedes the formation of structural atherosclerotic changes. Improvements in noninvasive
imaging modalities, mainly in ultrasound imaging, have made it possible to assess the
endothelial health of asymptomatic children with or without cardiovascular risk factors. By
using noninvasive ultrasound for endothelial function, important insights have been gained
into the early stages of atherosclerosis and the effects of cardiovascular risk factors on
vasculature in childhood. The ultrasound test of endothelial function is affordable, available,
and safe and may be considered a potent aid in clinical risk stratification of children at high
risk for subsequent clinical atherosclerosis in adulthood. At present, this methodology serves
only research purposes, as many issues including reproducibility and normal values for healthy
children need to be solved before clinical use can be considered. In adults, however, recent
studies have shown that attenuated endothelial function predicts the occurrence of future
cardiovascular events.
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Endothelial function
The vascular endothelial layer was first considered an inert border that discriminates
the vascular wall from the circulating blood stream (Florey 1966). Today the
endothelium is recognized as an active organ, responsible for the maintenance of
vascular homeostasis in the physiological state. The intact endothelial layer has many
antiatherogenic properties: it takes part in the control of arterial tone (Furchgott and
Vanhoutte 1989), helps to control proliferation of the underlying arterial smooth
muscle cells (Scott-Burden et al 1992), and regulates cell-to-cell interactions by
inhibiting thrombocyte aggregation and monocyte adhesion, which constitute
important steps in the pathogenesis of atherosclerosis (Vanhoutte 1988, 1991).
Research by Furchgott and Zawadzki (1980) demonstrated a pivotal role for
endothelial cells in the maintenance of vasodilatation by releasing vasoactive
mediators and led to the appreciation of the endothelial layer as a natural inhibitor of
atherogenesis.
Under normal conditions, the endothelial layer favors vasodilation over
vasoconstriction by releasing vasodilatory substances, mainly nitric oxide (NO) and
prostacycline (Ignarro et al 1987; Cohen and Vanhoutte 1995). The physiological
atheroprotective function of the endothelium is, however, rapidly attenuated in the
presence of atherosclerotic risk factors and toxic substances and conditions (Vanhoutte
1998). The attenuation of endothelial function may be a key event in atherogenesis,
which precedes the development of structural and clinical atherosclerosis (Ross 1986).
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In addition to being an early event in atherogenesis,
endothelial dysfunction is important in the later stages of
atherosclerotic diseases, predisposing individuals to
complications, such as thrombotic events.
Ultrasound assessment of
endothelial function
The long preclinical phase of atherosclerotic diseases
provides a window for noninvasive assessment of subclinical
atherosclerosis before ischemic symptoms appear. Lack of
accurate diagnostic tests of preclinical atherosclerosis,
however, has hampered the ability to detect and monitor
early atherosclerosis. The development of diagnostic tests
to detect subclinical disease could facilitate the early
diagnosis and management of high-risk individuals in
childhood. These tests should be noninvasive, safe, accurate,
reproducible, and relatively inexpensive to allow for the
clinical testing of apparently healthy individuals for risk
stratification purposes. The measurement of arterial
endothelial function might be a useful test, as endothelial
health reflects the propensity of the vascular tree to develop
early atherosclerosis.
Experimental studies performed in the early 1970s
demonstrated in vivo that local increase in blood flow causes
arterial dilatation (Lie et al 1970). Later this finding was
corroborated by human studies showing flow-mediated
dilatation (FMD) of the brachial artery (Sinoway et al 1989).
Joannides and co-workers (1995) discovered that FMD,
induced by reactive hyperemia, was dependent on intact
endothelial layer and was mediated by NO. Many studies
during recent years have utilized this physiologic
phenomenon to study vascular endothelial function by
measuring changes in the diameter of the conduit arteries
(such as the brachial or femoral) using noninvasive
ultrasound (Raitakari and Celermajer 2000). The ultrasound
measurement of endothelial function in children was
first described by Celermajer and co-workers in 1992
(Celermajer et al 1992). The test is based on the measure-
ment of the brachial artery diameter at baseline and after an
increase in blood flow caused by inflating and then deflating
a forearm blood pressure cuff. In this test, the proportional
increase in luminal diameter induced by hyperemia is
calculated and used as a marker of systemic endothelial
function. The FMD response is traditionally measured at
60s post-occlusion (Celermajer et al 1992). Later studies
have demonstrated that the arterial dilatation response to
ischemia-induced reactive hyperemia is mediated through
increased release of endothelial nitric oxide (NO), when
arterial occlusion times not greater than 5 minutes are used
(Mullen et al 2001). Sørensen and coworkers (1995) have
previously studied the accuracy and reproducibility of the
brachial ultrasound method and shown that although the
day-to-day within-subject variation in FMD is rather
substantial, the long-term within-subject variation during
weeks and months is acceptable and the measurement of
FMD is reproducible. In recent studies, the day-to-day
within-subject variation has varied greatly, with coefficients
of variation ranging between 9% and 50% (De Roos et al
2003; Järvisalo et al 2003; Malik et al 2004). Much of the
long-term variation in FMD measurements is due to
physiological fluctuation in endothelial function and not
measurement error, as the long-term reproducibility of
brachial artery baseline diameter measurements is excellent
(Sørensen et al 1995). Individual ultrasound laboratories
should, however, commit to repetitive testing of measure-
ment reproducibility and quality control, and the training
of ultrasound technicians should be performed with great
care. Computer software has been developed for automated
analysis of brachial ultrasound image sequences. These
automated methods provide a decreased analysis bias,
increased reproducibility, and improved measurement
accuracy. Consequently, inter- and intraobserver as well as
interinstitution variability are lower (Herrington et al 2001;
Woodman et al 2001; Sonka et al 2002).
There are currently few large-scale studies published on
FMD in children. In the largest population-based FMD study
comprising 333 British children, the mean FMD at 60s post-
occlusion was 4.7 ± 4.3% (Leeson et al 2001), whereas in a
sample of 105 healthy Finnish children, the mean maximal
FMD was 7.7 ± 4% (Järvisalo et al 2002). In a large sample
of 4040 subjects aged 14–98 years, the mean FMD was
4.4 ± 0.9% (Herrington et al 2001), and in 2109 Finnish 24-
to 39-year-old adults, the mean FMD was 7.0 ± 4.0% for
men and 8.8 ± 4.6% for women (Juonala 2005). Therefore,
there is still controversy on the normal values for FMD in
children and adults, although some previous papers have
defined endothelial dysfunction as FMD less than 3%
(Adams et al 1996; Järvisalo, Raitakari, et al 2004).
An international task force of experts in the field has
recently stated its recommendations on the execution of the
ultrasound test for endothelial function (Corretti et al 2002).
By using this test, endothelial dysfunction has been
demonstrated to associate with several risk factors in adults,
such as high serum low-density lipoprotein (LDL) and total
cholesterol (Celermajer et al 1992), serum high-density
lipoprotein (HDL) cholesterol (Toikka et al 1999), cigaretteVascular Health and Risk Management 2005:1(3) 229
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smoking (Celermajer, Sørensen, Georgakopoulos, et al
1993; Raitakari et al 1999), hypertension (Muiesan et al
1999), diabetes (Clarkson et al 1996), markers of oxidized
LDL (Heitzer et al 1996), visceral obesity (Hashimoto et al
1998), mental stress (Spieker et al 2002), and family history
of premature myocardial infarction (Gaeta et al 2000). The
brachial artery dilator response to increased shear stress has
been shown to correlate significantly with invasive testing
of brachial (Irace et al 2001) and coronary endothelial
function (Anderson et al 1995), as well as with the extent
and severity of coronary atherosclerosis (Neunteufl et al
1997) and carotid artery intima-media thickness (Gaeta et
al 2000). Furthermore, recent studies have shown that
brachial artery endothelial dysfunction is an independent
predictor of the occurrence of cardiovascular events in adults
(Perticone et al 2001; Gokce et al 2003).
The ultrasound assessment of systemic arterial
endothelial function is usually performed in the brachial
artery, because of a more suitable luminal diameter
compared with the radial artery and because it is more easily
examined than the femoral artery. In pre-pubertal children,
the measurements can, however, be reliably performed in
the femoral artery in addition to the brachial artery. It is
known that brachial artery diameter is inversely associated
with FMD (Järvisalo et al 2000). Arteries less than 2.5 mm
in diameter (mostly seen in children) present a potential
limitation to the ultrasound technique as the risk for “off-
center” imaging, and thereby, inaccurate diameter
measurements increases as the diameter becomes smaller
(Corretti et al 1995; Stadler et al 1996).
For reliable assessment of small changes in luminal
diameter, ultrasound transducer frequencies equal to or
greater than 7 MHz are required to achieve a satisfactory
resolution. The noninvasive nature of the brachial artery
ultrasound test has made it possible to assess systemic
endothelial function in children and adolescents with or
without cardiovascular risk factors. Studies in children have
demonstrated that coronary risk factors may lead to
attenuated endothelial function arising in childhood.
The brachial artery ultrasound test for endothelial
function usually includes administration of sublingual
nitrates to examine the vasodilating effect of an exogenous
source of NO. Nitric oxide acts directly at the level of the
arterial smooth muscle cells and produces an endothelium-
independent dilatation response. Nitrate-mediated dilatation
(NMD) therefore serves as a control test for the FMD
measurement to ensure that a decreased FMD capacity
observed is truly a consequence of endothelial dysfunction,
and not a reflection of underlying smooth muscle
dysfunction. Recent evidence indicates that in addition to
influencing endothelial function, atherosclerosis may also
induce changes in arterial dilatation responses to exogenous
NO (Adams et al 1998; Raitakari et al 2001). Adult patients
with coronary artery disease show impaired brachial NMD
compared with healthy controls (Raitakari et al 2001).
Attenuated NMD is associated with serum cholesterol
concentration independent of endothelial function in
apparently healthy adults (Adams et al 1998). In most
previous studies in children, the NMD responses have
actually been mildly reduced in high-risk individuals
although the difference has not reached statistical
significance, possibly due to limited sample size (Celermajer
et al 1992; Celermajer, Sørensen, Ryalls, et al 1993; Singh
et al 2003). We have recently shown that impaired NMD is
closely associated with low FMD, increased oxidized LDL
and higher intima-media thickness in healthy and high-risk
children (Järvisalo, Lehtimäki, et al 2004). These findings
suggest that decreased dilatation response to exogenous NO
donors occurs in children at increased risk for atherosclerosis.
Hypercholesterolemia and
endothelial function in children
Familial hypercholesterolemia (FH) is a common autosomal
dominant inherited disorder of the LDL cholesterol
metabolism in which elimination of LDL cholesterol is
impaired as a result of defects in the LDL receptor (Goldstein
and Brown 1973). Subjects with untreated heterozygous FH
develop coronary heart disease (CHD) 15–20 years earlier
than healthy subjects. Children with heterozygous FH show
impaired FMD at the age of 6–7 years (Sørensen et al 1994;
de Jongh, Lilien, Bakker, et al 2002). In one study, a positive
family history for cardiovascular disease was shown to carry
additional risk in children with FH (de Jongh, Lilien, Bakker,
et al 2002). In children with FH, the correlation between
serum LDL concentration and FMD has been shown in one
study (Aggoun et al 2000), but not all (Sørensen et al 1994;
Mietus-Snyder and Malloy 1998). However, in a relatively
large group of healthy normocholesterolemic children, LDL
cholesterol concentration was inversely correlated with FMD
responses (Järvisalo et al 2002). In the study by Sørensen
et al (1994), serum Lp(a) level was inversely associated with
FMD in FH children independent of serum cholesterol. FMD
has also been shown to be impaired in children with familial
combined hyperlipidemia, another common form of




Type 1 diabetes is an important risk factor for cardiovascular
events. Individuals with diabetes have a two- to fourfold
increased risk of developing atherosclerotic diseases, which
is inadequately explained by differences in the levels of
traditional vascular risk factors (Pyörälä et al 1987).
Wiltshire et al (2002) studied FMD in 36 diabetic children
with a mean age of 14 years and a mean duration of diabetes
of under 6 years. These diabetic children without diabetic
complications had attenuated endothelial function compared
with controls. In their study, diabetic endothelial dysfunction
was correlated with red cell folate concentration. Disease
duration and glycemic control, however, were not associated
with endothelial dysfunction in these children (Wiltshire et
al 2002). Previously, Donaghue and co-workers (1997)
demonstrated in a study of 20 diabetic adolescents that
young diabetics with clinical complications had decreased
endothelial and smooth muscle function compared with
healthy controls. We have recently shown that endothelial
dysfunction is commonly found in young children with type
1 diabetes, and that those diabetic children affected by
impaired FMD are at risk of having increased carotid artery
wall thickness, which is a structural marker of early
atherosclerosis (Järvisalo Raitikari, Toikka, et al 2004).
These findings suggest that endothelial dysfunction in
children with type 1 diabetes may predispose them to the
development of early atherosclerosis.
Other risk factors associated with
endothelial dysfunction in
childhood
Recent studies have associated childhood obesity, a
condition with steeply increasing prevalence, with
endothelial dysfunction (Woo et al 2004). The effect of low
birth weight on later endothelial dysfunction has been the
topic of several studies as it has been associated with
increased risk for CHD. Singhal and co-workers (2001)
studied prematurely born children and found no differences
in endothelial function compared with control children. In
another small-scale study, low birth weight was associated
with endothelial dysfunction in healthy 9-year-old children
(Martin et al 2000), and there are data indicating that low
birth weight may influence endothelial function even in
adulthood (Leeson et al 2001). Also, rarer conditions such
as chronic renal failure (Kari et al 1997), homozygous
homocystinuria (Celermajer, Sørensen, Ryalls, et al 1993),
HIV infection (Bonnet et al 2004), lupus erythematosus
(Soep et al 2004), and Henoch-Schonlein purpura (Kurotobi
et al 2004) have been associated with impaired FMD in
children. Gaeta et al (2000) showed that the young adult
off-spring of patients who had experienced premature
myocardial infarction have attenuated FMD compared with
matched control subjects. Conversely, endothelial function
has been shown to be directly correlated with habitual
physical activity in 5- to 10-year-old children (Abbott et al
2002). So far no studies have associated childhood
hypertension with endothelial dysfunction (Leeson et al
1997; Järvisalo et al 2002).
Is childhood endothelial
dysfunction reversible?
Childhood endothelial function has been shown to be
potentially reversible by the use of combined tocopherol
and ascorbic acid antioxidant therapy in hypercholesterol-
emic chidren (Mietus-Snyder and Malloy 1998; Engler et
al 2003). In a recent study, de Jongh and co-workers
demonstrated in a randomized, placebo-controlled setting
that early simvastatin therapy of 10–40 mg daily restores
endothelial function in 28 weeks in 9- to 18-year-old
children with heterozygous familial hypercholesterolemia
(de Jongh, Lilien, op’t Roodt, et al 2002). No improvement
in FMD was, however, observed with plant sterol therapy
in FH children despite a contemporaneous decrease in serum
LDL concentration (de Jongh et al 2003). Folic acid therapy
has lately been shown to improve endothelial function in
children with chronic renal failure (Bennett-Richards et al
2002) and in children with type 1 diabetes (Pena et al 2004).
Several recent studies have demonstrated that obesity-related
endothelial dysfunction can be ameliorated by increasing
exercise and improving dietary habits (Watts et al 2004a,
2004b; Woo et al 2004). Recent findings have led to attempts
to develop drugs directly aimed to treat and reverse the
arterial wall pathology instead of merely diminishing risk
factor load. For some drugs, such as the statin group, it seems
that in addition to the lowering of serum cholesterol levels
they carry pleiotropic effects including direct beneficial
effects on the endothelium. In children, the data on effects of
intervention strategies on arterial indices are currently very
limited, although available evidence supports the positive
effects of statin (de Jongh, Lilien, op’t Roodt, et al 2002)
and antioxidant (Mietus-Snyder and Malloy 1998) therapies
on endothelial function in hypercholesterolemic children.Vascular Health and Risk Management 2005:1(3) 231
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Clinical implications of endothelial
dysfunction in children
Atherosclerosis is a chronic progressive condition that
originates in childhood and is accelerated in the presence
of cardiovascular risk factors. Risk factors for atherosclerosis
show remarkable tracking and clustering, therefore early
interventions in young subjects with increased risk factor
load are invaluable and constitute the basis of primary
prevention of coronary artery disease. The long asympto-
matic phase of atherosclerotic diseases provides an
opportunity for early primary prevention measures when
the subjects that benefit the most from these interventions
are carefully identified.
The development of imaging methods for the non-
invasive assessment of endothelial function in children
carries remarkable potential for clinical risk stratification.
Ultrasonic assessment of arterial endothelial function meets
the requirements for safety, price, and availability, and today
the techniques and imaging methods have been refined to
create reproducible, reliable results. No data are yet available
on the predictive value of childhood endothelial function
on cardiovascular prognosis but the data in adults are
convincing.
The ultrasound method for assessment of endothelial
function might prove valuable in determining the true
benefits of early pharmaceutical risk factor management in
high-risk children. However, further longitudinal studies are
needed before these techniques may be accepted for tools
in routine clinical practice as there are currently no data on
whether an improvement in endothelial function during
childhood will translate into decreased risk of future
cardiovascular disease.
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